Ziopharm Oncology Announces Initiation of Phase 1 Trial Evaluating Rapid Personalized Manufacturing CAR-T Technology in Patients with Relapsed CD19+ Leukemias and Lymphomas

NEXT STORY
Avis Budget Group to Deliver Avis Safety Pledge and Budget Worry-Free Promise Through Agreements With Lysol, Hip Hop Public Health and Renowned Group of Medical Professionals
PREV STORY
electroCore to Participate in Three Upcoming Virtual Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Lexicon Pharmaceuticals Announces Publication of Positive Data for Zynquista™ (Sotagliflozin) on Cardiorenal Clinical Biomarkers in Adults With Type 1 Diabetes

author_avatar
NASDAQ Market News

Smart Biosensors Market Research Report by Product Type, by Technology, by Application, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

author_avatar
NASDAQ Market News

Summit Therapeutics Publishes Scientific Updates to Corporate Website

author_avatar
NASDAQ Market News